✦ LIBER ✦

Levodopa in Parkinson's disease: effect on mortality

✍ Scribed by R. J. Marttila; U. K. Rinne; V. Sonninen

Book ID: 114781745
Publisher: John Wiley and Sons
Year: 2009
Tongue: English
Weight: 116 KB
Volume: 69
Category: Article
ISSN: 0001-6314
DOI: 10.1111/j.1600-0404.1984.tb02382.x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Mortality of patients with parkinson's d

Mortality of patients with parkinson's disease treated with levodopa

✍ R. J. Marttila; U. K. Rinne; T. Siirtola; V. Sonninen 📂 Article 📅 1977 🏛 Springer 🌐 English ⚖ 372 KB

The effect of levodopa on the mortality of patients with Parkinson's disease was investigated in 349 patients treated with levodopa or levodopa combined with decarboxylase inhibitor during 1969-1975 inclusive. During the study period, 61 patients died. The expected mortality was 32.99 resulting in a

Effect of levodopa treatment on contrast

Effect of levodopa treatment on contrast sensitivity in Parkinson's disease

✍ Dr C. Bulens; J. D. Meerwaldt; G. J. Van der Wildt; J. B. P. Van Deursen 📂 Article 📅 1987 🏛 John Wiley and Sons 🌐 English ⚖ 425 KB 👁 3 views

Effect of levodopa on limits of stabilit

Effect of levodopa on limits of stability in Parkinson's disease

✍ M. Mancini; L. Rocchi; L. Chiari; F.B. Horak 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 175 KB

Parkinson's disease/Parkinson syndromes—

Parkinson's disease/Parkinson syndromes—therapy: Levodopa

📂 Article 📅 1992 🏛 John Wiley and Sons 🌐 English ⚖ 249 KB

Three patients with Parlcinson's disease, optimally treated with levodopdcabidopa (LDKD) tablets, but experiencing severe motor fluctuations, were administered a solution of levodopd carbidopalascorbic acid (LCAS) orally at intervals ranging from 30 to 60 minutes. Patients were rated half-hourly to

Sensorimotor disinhibition in Parkinson'

Sensorimotor disinhibition in Parkinson's disease: Effects of levodopa

✍ Dr Michael P. Caligiuri; William C. Heindel; James B. Lohr 📂 Article 📅 1992 🏛 John Wiley and Sons 🌐 English ⚖ 519 KB

Protease inhibitors enhance levodopa eff

Protease inhibitors enhance levodopa effects in Parkinson's disease

✍ Dominique Caparros-Lefebvre; Annie Lannuzel; François Tiberghien; Michel Strobel 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 50 KB 👁 2 views

We read with interest the recent article by Martı `-Masso `and Poza 1 but we were surprised that our previous paper 2 on the same topic was not quoted by the authors. In fact, the prospective follow-up study 2 we have carried out over a median 5-year period in a small population of patients with cin